PE
BIO icon

Point72 Europe’s Bio-Rad Laboratories Class A BIO Stock Holding History

Point72 Europe’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$137K Buy
+489
New +$133K 0.01% 236
2024
Q1 		– Sell
-39,449
Closed -$12.7M – 147
2023
Q4 		$12.7M Buy
+39,449
New +$12.4M 1.6% 15
2023
Q3 		– Sell
-5,833
Closed -$2.21M – 94
2023
Q2 		$2.21M Buy
+5,833
New +$2.37M 0.29% 82

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Point72 Europe's BIO Position: Q3 2025 in Review

Point72 Europe opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2025: 489 shares worth $137K. The stake represents 0.01% of the portfolio and ranks #236 among its holdings. This is a return to the name: Point72 Europe previously reported a position in BIO as recently as Q4 2023.

Point72 Europe first reported a position in BIO in Q2 2023 and has held it in 3 quarters since. The position peaked at $12.7M in Q4 2023. 396 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Point72 Europe held 489 shares of Bio-Rad Laboratories Class A worth $137K as of Q3 2025.
  • Bio-Rad Laboratories Class A was a new Point72 Europe position in Q3 2025.
  • Bio-Rad Laboratories Class A made up 0.01% of Point72 Europe's portfolio in Q3 2025, its #236 holding.
  • Point72 Europe first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and has held it in 3 quarters since.
  • Point72 Europe's Bio-Rad Laboratories Class A position peaked at $12.7M in Q4 2023.
  • 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.